Literature DB >> 28781776

Unraveling the genes implicated in Alzheimer's disease.

Mohan Giri1, Abhilasha Shah1, Bibhuti Upreti1, Jayanti Chamling Rai1.   

Abstract

Alzheimer's disease (AD) is a heterogeneous neurodegenerative disorder and it is the most common form of dementia in the elderly. Early onset AD is caused by mutations in three genes: Amyloid-β precursor protein, presenilin 1 (PSEN1) and PSEN2. Late onset AD (LOAD) is complex and apolipoprotein E is the only unanimously accepted genetic risk factor for its development. Various genes implicated in AD have been identified using advanced genetic technologies, however, there are many additional genes that remain unidentified. The present review highlights the genetics of early and LOAD and summarizes the genes involved in different signaling pathways. This may provide insight into neurodegenerative disease research and will facilitate the development of effective strategies to combat AD.

Entities:  

Keywords:  Alzheimer's disease; biomarker; gene; genetics; mutation

Year:  2017        PMID: 28781776      PMCID: PMC5526178          DOI: 10.3892/br.2017.927

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  124 in total

1.  PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease.

Authors:  Bart Dermaut; Esther A Croes; Rosa Rademakers; Marleen Van den Broeck; Marc Cruts; Albert Hofman; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

2.  Reelin binds alpha3beta1 integrin and inhibits neuronal migration.

Authors:  L Dulabon; E C Olson; M G Taglienti; S Eisenhuth; B McGrath; C A Walsh; J A Kreidberg; E S Anton
Journal:  Neuron       Date:  2000-07       Impact factor: 17.173

3.  A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

Authors:  Ute Dreses-Werringloer; Jean-Charles Lambert; Valérie Vingtdeux; Haitian Zhao; Horia Vais; Adam Siebert; Ankit Jain; Jeremy Koppel; Anne Rovelet-Lecrux; Didier Hannequin; Florence Pasquier; Daniela Galimberti; Elio Scarpini; David Mann; Corinne Lendon; Dominique Campion; Philippe Amouyel; Peter Davies; J Kevin Foskett; Fabien Campagne; Philippe Marambaud
Journal:  Cell       Date:  2008-06-27       Impact factor: 41.582

4.  CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.

Authors:  Jeremy Koppel; Fabien Campagne; Valérie Vingtdeux; Ute Dreses-Werringloer; Michael Ewers; Dan Rujescu; Harald Hampel; Marc L Gordon; Erica Christen; Julien Chapuis; Blaine S Greenwald; Peter Davies; Philippe Marambaud
Journal:  Mol Med       Date:  2011-05-24       Impact factor: 6.354

5.  Variant TREM2 as risk factor for Alzheimer's disease.

Authors:  Harald Neumann; Mark J Daly
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

6.  Activation and functional characterization of the mosaic receptor SorLA/LR11.

Authors:  L Jacobsen; P Madsen; C Jacobsen; M S Nielsen; J Gliemann; C M Petersen
Journal:  J Biol Chem       Date:  2001-04-09       Impact factor: 5.157

7.  Genetic association of CTNNA3 with late-onset Alzheimer's disease in females.

Authors:  Akinori Miyashita; Hiroyuki Arai; Takashi Asada; Masaki Imagawa; Etsuro Matsubara; Mikio Shoji; Susumu Higuchi; Katsuya Urakami; Akiyoshi Kakita; Hitoshi Takahashi; Shinichi Toyabe; Kohei Akazawa; Ichiro Kanazawa; Yasuo Ihara; Ryozo Kuwano
Journal:  Hum Mol Genet       Date:  2007-08-30       Impact factor: 6.150

8.  The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.

Authors:  Ewa Bromek; Anna Haduch; Władysława A Daniel
Journal:  Eur J Pharmacol       Date:  2009-10-08       Impact factor: 4.432

9.  Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele.

Authors:  Wendy Wei Qiao Qiu; Angela Lai; Timothy Mon; Mkaya Mwamburi; Warren Taylor; James Rosenzweig; Neil Kowall; Robert Stern; Haihao Zhu; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2013-04-03       Impact factor: 4.105

10.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

View more
  6 in total

Review 1.  Extracellular Vesicle Biology in Alzheimer's Disease and Related Tauopathy.

Authors:  Annina M DeLeo; Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2017-11-28       Impact factor: 4.147

2.  Network medicine for disease module identification and drug repurposing with the NeDRex platform.

Authors:  Sepideh Sadegh; James Skelton; Elisa Anastasi; Judith Bernett; David B Blumenthal; Gihanna Galindez; Marisol Salgado-Albarrán; Olga Lazareva; Keith Flanagan; Simon Cockell; Cristian Nogales; Ana I Casas; Harald H H W Schmidt; Jan Baumbach; Anil Wipat; Tim Kacprowski
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

Review 3.  Endothelial Progenitor Cells and Vascular Alterations in Alzheimer's Disease.

Authors:  Antía Custodia; Alberto Ouro; Daniel Romaus-Sanjurjo; Juan Manuel Pías-Peleteiro; Helga E de Vries; José Castillo; Tomás Sobrino
Journal:  Front Aging Neurosci       Date:  2022-01-26       Impact factor: 5.750

Review 4.  Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration.

Authors:  Daniel Romaus-Sanjurjo; Uxía Regueiro; Maite López-López; Laura Vázquez-Vázquez; Alberto Ouro; Isabel Lema; Tomás Sobrino
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 6.208

Review 5.  Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases.

Authors:  Antía Custodia; Daniel Romaus-Sanjurjo; Marta Aramburu-Núñez; Diego Álvarez-Rafael; Laura Vázquez-Vázquez; Javier Camino-Castiñeiras; Yago Leira; Juan Manuel Pías-Peleteiro; José Manuel Aldrey; Tomás Sobrino; Alberto Ouro
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

6.  Transcriptome Profile of Nicotinic Receptor-Linked Sensitization of Beta Amyloid Neurotoxicity.

Authors:  Komal Arora; Mahdi Belcaid; Megan J Lantz; Ruth Taketa; Robert A Nichols
Journal:  Sci Rep       Date:  2020-03-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.